Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Stock Short Interest Report for October

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) saw a significant drop in short interest in October. As of October 30th, there was short interest totaling 2,739 shares, a drop of 81.0% from the October 15th total of 14,383 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 128,792 shares, the short-interest ratio is presently 0.0 days.

Cuprina Holdings (Cayman) Trading Down 2.3%

Shares of Cuprina Holdings (Cayman) stock traded down $0.04 during trading on Thursday, hitting $1.68. 12,159 shares of the company’s stock traded hands, compared to its average volume of 1,005,260. Cuprina Holdings has a 1 year low of $1.45 and a 1 year high of $14.80. The business has a 50-day simple moving average of $2.12 and a 200-day simple moving average of $2.96.

Analyst Ratings Changes

Separately, Weiss Ratings lowered shares of Cuprina Holdings (Cayman) from a “sell (d-)” rating to a “sell (e+)” rating in a report on Tuesday, October 13th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

Cuprina Holdings (Cayman) Company Profile

Cuprina Holdings (Cayman) Limited is a medical technology company focused on developing and commercializing products for wound care and tissue repair. The company’s business is centered on medical devices and biologically derived materials intended to support the management of wounds and related clinical applications. Cuprina serves the healthcare market through products designed for use by medical professionals in wound-treatment settings. Its offerings are associated with advanced wound-care applications, including products based on porcine-derived materials and other biological technologies.